Related Experiment Video
Updated: Mar 28, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
A splicing mutation of proteolipid protein 1 in Pelizaeus-Merzbacher disease
Taku Omata1, Jun-Ichi Nagai2, Hiroko Shimbo3
1Division of Child Neurology, Chiba Children's Hospital, Chiba, Japan.
Abstract:
A patient with an unusually mild form of Pelizaeus-Merzbacher disease was studied. Clinically, mild developmental delay with acquisition of assisted walking at 16months and mild spastic tetraplegia were evident, but no nystagmus, cerebellar, or extra-pyramidal signs were present. PLP1 mutation analysis revealed a nucleotide substitution adjacent to the acceptor site of intron 3, NM_000533.4:c.454-9T>G. Expression analysis using the patient's leukocytes demonstrated an additional abnormal transcript including the last 118bp of intron 3. In silico prediction analysis suggested the reduction of wild-type acceptor activity, which presumably evokes the cryptic splicing variant. Putative cryptic transcript results in premature termination, which may explain the mild clinical phenotype observed in this patient.
Insights
This study details a mild Pelizaeus-Merzbacher disease case caused by a novel PLP1 gene mutation. The mutation leads to abnormal splicing, resulting in a premature stop codon and a less severe clinical presentation.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Pelizaeus-Merzbacher disease (PMD) is a rare, inherited neurological disorder.
- It is typically caused by mutations in the proteolipid protein 1 (PLP1) gene, leading to severe symptoms.
- Mild forms of PMD are less understood, particularly regarding their molecular basis.
Observation:
- A patient presented with mild developmental delay and spastic tetraplegia, but lacked typical PMD signs like nystagmus.
- Genetic analysis identified a specific nucleotide substitution (c.454-9T>G) near an intron splice site in the PLP1 gene.
- Leukocyte expression analysis revealed an abnormal transcript containing intronic sequence.
Findings:
- The identified PLP1 mutation (c.454-9T>G) likely disrupts normal mRNA splicing.
- In silico analysis predicted reduced wild-type splice acceptor activity, favoring a cryptic splice site.
- This cryptic splicing results in a transcript with a premature termination codon, explaining the milder phenotype.
Implications:
- This finding expands the spectrum of PLP1 mutations associated with Pelizaeus-Merzbacher disease.
- Understanding genotype-phenotype correlations in PMD is crucial for diagnosis and prognosis.
- The study highlights the impact of subtle splicing alterations on disease severity.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Long-patch Base Excision Repair

